Terns Pharmaceuticals (TERN) Q4 2024 Annual Earnings
TERN·Reported March 20, 2025·Before market open
Diluted EPS came in at $-0.24, beat the $-0.30 consensus by $0.06.
Diluted EPS
$-0.24beat by $0.06
Consensus: $-0.30
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Terns Pharmaceuticals's Q4 2024 earnings report.
Terns Pharmaceuticals (TERN) reported Q4 2024 earnings on March 20, 2025 before market open.
Terns Pharmaceuticals reported diluted EPS of $-0.24 for Q4 2024.
EPS beat the consensus estimate of $-0.30 by $0.06.
You can read the 10-K periodic report (0000950170-25-042695) directly on SEC EDGAR. The filing index links above go to sec.gov.